1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
  4. > Dysmenorrhea-Pipeline Insights, 2017

Dysmenorrhea-Pipeline Insights, 2017

  • January 2017
  • -
  • Delve Insight


DelveInsight’s, “ Dysmenorrhea-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Dysmenorrhea. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Dysmenorrhea. DelveInsight’s Report also assesses the Dysmenorrhea therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Please note:This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication.

Scope

- The report provides competitivepipeline landscape of Dysmenorrhea
- The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
- Coverage of the Dysmenorrhea pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Dysmenorrhea and also provide company profiling
- The report also gives the information of dormant and discontinued pipeline projects
- Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

Table Of Contents

Dysmenorrhea-Pipeline Insights, 2017
Illustrative

- Dysmenorrhea Overview
- Dysmenorrhea Pipeline Therapeutics
- Dysmenorrhea Therapeutics under Development by Companies
- Dysmenorrhea Filed and Phase III Products
- Comparative Analysis
- Dysmenorrhea Phase II Products
- Comparative Analysis
- Dysmenorrhea Phase I and IND Filed Products
- Comparative Analysis
- Dysmenorrhea Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Dysmenorrhea - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Dysmenorrhea - Discontinued Products
- Dysmenorrhea - Dormant Products
- Companies Involved in Therapeutics Development for Dysmenorrhea
- Appendix
- Methodology
- Contact Us
- Disclaimer


List of Tables

- Number of Products under Development for Dysmenorrhea, 2017
- Number of Products under Development by Companies
- Comparative Analysis by Filed and Phase III Products, 2017
- Comparative Analysis Phase II Products, 2017
- Comparative Analysis Phase I and IND Filed Products, 2017
- Comparative Analysis Discovery and Pre-Clinical Stage Products, 2017
- Drug Candidates Profiles
- Dysmenorrhea Assessment by Monotherapy Products
- Dysmenorrhea Assessment by Combination Products
- Dysmenorrhea Assessment by Route of Administration
- Dysmenorrhea Assessment by Stage and Route of Administration
- Dysmenorrhea Assessment by Molecule Type
- Dysmenorrhea Assessment by Stage and Molecule Type
- Dysmenorrhea Therapeutics - Discontinued Products
- Dysmenorrhea Therapeutics - Dormant Products
- Products under Development by Companies, 2017


List of Figures

- Number of Products under Development for Dysmenorrhea, 2017
- Filed and Phase III Products, 2017
- Phase II Products, 2017
- Phase I and IND Filed Products, 2017
- Discovery and Pre-Clinical Stage Products, 2017
- Dysmenorrhea Assessment by Monotherapy Products
- Dysmenorrhea Assessment by Combination Products
- Dysmenorrhea Assessment by Route of Administration
- Dysmenorrhea Assessment by Stage and Route of Administration
- Dysmenorrhea Assessment by Molecule Type
- Dysmenorrhea Assessment by Stage and Molecule Type

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Migraine  - Market Insights, Epidemiology and Market Forecast-2023

Migraine  - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • March 2017
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Migraine - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market ...

Dysmenorrhea  - Market Insights, Epidemiology and Market Forecast-2023

Dysmenorrhea  - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • March 2017
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Dysmenorrhea - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global ...

Global OTC Analgesics Market - Growth, Trends and Forecast (2017 - 2022)

Global OTC Analgesics Market - Growth, Trends and Forecast (2017 - 2022)

  • $ 4250
  • Industry report
  • February 2017
  • by Mordor Intelligence LLP

The global OTC Analgesics market accounted for a market value of USD XX billion in 2015. The market is expected to reach USD XX billion in 2016 and USD XX billion by 2021, growing at a CAGR of xx% during ...

Migraine-api Insights, 2017

January 2017 $ 1250

Download Unlimited Documents from Trusted Public Sources

The future of the Pain Relief Industry in the UK

  • February 2017
    5 pages
  • Pain Relief  

  • United Kingdom  

View report >

Pain Relief Industry in the US

  • January 2017
    7 pages
  • Pain Relief  

  • United States  

View report >

Pain Relief Industry in the US

  • January 2017
    20 pages
  • Pain Relief  

    Therapy  

  • United States  

View report >

Otc Markets In China

4 months ago

Related Market Segments :

Pain Relief

ref:plp2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.